Artemisinin to Reduce The Symptoms of Schizophrenia

Clinical trial NCT00753506 · COMPLETED

Trial details

NCT number: NCT00753506
Sponsor: Sheppard Pratt Health System
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder

Start date: 2008-08-01
Primary completion: 2010-05-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.